Skip to Content


Shefali Luthra, quoting Rachel Sachs (Academic Fellow Alumna)
Salon
May 27, 2018

Read the full article

From the article:

Importation backers — including the National Academy for State Health Policy (NASHP), which helped craft Vermont’s bill and has worked with state lawmakers — hope he’ll reverse these positions. But few are optimistic that this will happen.

“I don’t expect that Vermont alone will be able to bring sufficient pressure to bear on Secretary Azar to convince him to change his mind,” said Rachel Sachs, an associate law professor at Washington University in St. Louis, who tracks drug-pricing laws.

A state’s importation program would also require buy-in from Canadian wholesalers. What’s in it for them?

Read more here!

Read the full article

Tags

fda   health law policy   pharmaceuticals   rachel sachs   regulation